Somatostatin reduces 3H-thymidine incorporation and c-myc, but not thyroglobulin ribonucleic acid levels in human thyroid follicular cells in vitro

J Clin Endocrinol Metab. 1991 Jun;72(6):1364-71. doi: 10.1210/jcem-72-6-1364.

Abstract

The action of somatostatin (SRIH) on 3H-thymidine (thy) incorporation and on c-myc and thyroglobulin RNA levels in a suspension of follicles from normal and goitrous human thyroid was examined. SRIH, at 10(-7) M concentration, inhibited basal thy incorporation (maximally by 4 h lasting for up 24 h), which effect was greater in goiter than in normal thyroid and was also detected in growing adherent epithelial cells. Moreover, in a follicle suspension SRIH prevented TSH-stimulated thy incorporation, both in normal and in goitrous thyroid. Basal expression of c-myc RNA was not affected by SRIH in either tissue, whereas the TSH-stimulated c-myc RNA level was significantly reduced in goiter. No effect of SRIH was observed on basal or TSH-stimulated thyroglobulin RNA levels. SRIH did not alter basal cAMP concentrations in normal or goitrous follicles, but it significantly reduced TSH-stimulated cAMP accumulation both in normal thyroid and in goiter. Overall, our data indicate a direct inhibitory action of SRIH on growth, but not on differentiation, of human thyroid, probably by a mechanism not entirely cAMP dependent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Female
  • Goiter / metabolism
  • Goiter / pathology
  • Humans
  • Male
  • Proto-Oncogene Proteins c-myc / genetics*
  • RNA / metabolism*
  • Reference Values
  • Somatostatin / pharmacology*
  • Thymidine / metabolism*
  • Thyroglobulin / genetics*
  • Thyroid Gland / cytology
  • Thyroid Gland / metabolism*
  • Thyroid Gland / pathology
  • Tritium

Substances

  • Proto-Oncogene Proteins c-myc
  • Tritium
  • Somatostatin
  • RNA
  • Thyroglobulin
  • Cyclic AMP
  • Thymidine